0 Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardiaSeptember 20, 2022PublicationBy Debbie Everidge0 Comments